Correlation Between C4 Therapeutics and Prelude Therapeutics
Can any of the company-specific risk be diversified away by investing in both C4 Therapeutics and Prelude Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining C4 Therapeutics and Prelude Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between C4 Therapeutics and Prelude Therapeutics, you can compare the effects of market volatilities on C4 Therapeutics and Prelude Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in C4 Therapeutics with a short position of Prelude Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of C4 Therapeutics and Prelude Therapeutics.
Diversification Opportunities for C4 Therapeutics and Prelude Therapeutics
0.49 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between CCCC and Prelude is 0.49. Overlapping area represents the amount of risk that can be diversified away by holding C4 Therapeutics and Prelude Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Prelude Therapeutics and C4 Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on C4 Therapeutics are associated (or correlated) with Prelude Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Prelude Therapeutics has no effect on the direction of C4 Therapeutics i.e., C4 Therapeutics and Prelude Therapeutics go up and down completely randomly.
Pair Corralation between C4 Therapeutics and Prelude Therapeutics
Given the investment horizon of 90 days C4 Therapeutics is expected to generate 1.47 times more return on investment than Prelude Therapeutics. However, C4 Therapeutics is 1.47 times more volatile than Prelude Therapeutics. It trades about 0.02 of its potential returns per unit of risk. Prelude Therapeutics is currently generating about -0.02 per unit of risk. If you would invest 672.00 in C4 Therapeutics on August 28, 2024 and sell it today you would lose (234.00) from holding C4 Therapeutics or give up 34.82% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
C4 Therapeutics vs. Prelude Therapeutics
Performance |
| Timeline |
| C4 Therapeutics |
| Prelude Therapeutics |
C4 Therapeutics and Prelude Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with C4 Therapeutics and Prelude Therapeutics
The main advantage of trading using opposite C4 Therapeutics and Prelude Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if C4 Therapeutics position performs unexpectedly, Prelude Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Prelude Therapeutics will offset losses from the drop in Prelude Therapeutics' long position.| C4 Therapeutics vs. Shattuck Labs | C4 Therapeutics vs. Eliem Therapeutics | C4 Therapeutics vs. Prelude Therapeutics | C4 Therapeutics vs. Monte Rosa Therapeutics |
| Prelude Therapeutics vs. Foghorn Therapeutics | Prelude Therapeutics vs. Shattuck Labs | Prelude Therapeutics vs. Monte Rosa Therapeutics | Prelude Therapeutics vs. Kymera Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Center module to all portfolio management and optimization tools to improve performance of your portfolios.
Other Complementary Tools
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories |